Wall Street brokerages forecast that Dolby Laboratories, Inc. (NYSE:DLB) will report $0.69 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have made estimates for Dolby Laboratories’ earnings. The lowest EPS estimate is $0.68 and the highest is $0.70. Dolby Laboratories reported earnings of $0.79 per share in the same quarter last year, which indicates a negative year over year growth rate of 12.7%. The firm is expected to report its next earnings results on Wednesday, January 23rd.

According to Zacks, analysts expect that Dolby Laboratories will report full-year earnings of $3.07 per share for the current fiscal year, with EPS estimates ranging from $2.99 to $3.14. For the next financial year, analysts expect that the company will post earnings of $3.44 per share, with EPS estimates ranging from $3.43 to $3.45. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow Dolby Laboratories.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Wednesday, October 24th. The electronics maker reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.17. The firm had revenue of $265.33 million during the quarter, compared to the consensus estimate of $272.42 million. Dolby Laboratories had a return on equity of 12.72% and a net margin of 10.43%. During the same period in the prior year, the firm posted $0.21 earnings per share.

DLB has been the subject of a number of research analyst reports. B. Riley cut their target price on Dolby Laboratories from $69.00 to $63.00 and set a “neutral” rating for the company in a research report on Thursday, October 25th. Tigress Financial restated a “buy” rating on shares of Dolby Laboratories in a research report on Friday, September 7th. R. F. Lafferty cut their target price on Dolby Laboratories from $81.00 to $80.00 and set a “buy” rating for the company in a research report on Monday, October 22nd. Barrington Research restated a “buy” rating and issued a $78.00 target price on shares of Dolby Laboratories in a research report on Thursday, July 26th. Finally, Zacks Investment Research restated a “sell” rating on shares of Dolby Laboratories in a research report on Tuesday, November 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $72.80.

In other news, SVP Giles Baker sold 5,000 shares of the stock in a transaction on Thursday, August 23rd. The stock was sold at an average price of $70.00, for a total transaction of $350,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lewis Chew sold 35,000 shares of the stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $69.44, for a total value of $2,430,400.00. The disclosure for this sale can be found here. Insiders sold 105,976 shares of company stock valued at $7,400,305 over the last 90 days. 43.74% of the stock is currently owned by insiders.

Several large investors have recently made changes to their positions in the company. Janus Henderson Group PLC lifted its position in shares of Dolby Laboratories by 16.2% during the 2nd quarter. Janus Henderson Group PLC now owns 3,801,592 shares of the electronics maker’s stock valued at $234,517,000 after acquiring an additional 530,188 shares during the last quarter. BlackRock Inc. lifted its position in shares of Dolby Laboratories by 12.4% during the 3rd quarter. BlackRock Inc. now owns 2,924,015 shares of the electronics maker’s stock valued at $204,594,000 after acquiring an additional 323,489 shares during the last quarter. FMR LLC lifted its position in shares of Dolby Laboratories by 5.1% during the 3rd quarter. FMR LLC now owns 2,607,991 shares of the electronics maker’s stock valued at $182,481,000 after acquiring an additional 127,537 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of Dolby Laboratories by 10.0% during the 3rd quarter. Renaissance Technologies LLC now owns 2,458,000 shares of the electronics maker’s stock valued at $171,986,000 after acquiring an additional 223,300 shares during the last quarter. Finally, Disciplined Growth Investors Inc. MN lifted its position in shares of Dolby Laboratories by 11.4% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 1,497,157 shares of the electronics maker’s stock valued at $104,756,000 after acquiring an additional 152,940 shares during the last quarter. Institutional investors own 57.38% of the company’s stock.

DLB opened at $66.29 on Friday. The company has a market capitalization of $6.92 billion, a price-to-earnings ratio of 27.62, a PEG ratio of 2.27 and a beta of 0.73. Dolby Laboratories has a 1-year low of $58.37 and a 1-year high of $74.29.

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 14th. Shareholders of record on Monday, November 5th were given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 1.15%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.16. The ex-dividend date was Friday, November 2nd. Dolby Laboratories’s dividend payout ratio is 31.67%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Featured Article: Outstanding Shares, Buying and Selling Stocks

Get a free copy of the Zacks research report on Dolby Laboratories (DLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.